Status:
COMPLETED
Technologically-Augmented Referrals to Mitigate Addiction Consequences
Lead Sponsor:
Washington State University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Use Disorders
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The implementation of screening and intervention for substance use disorders, such as Screening Brief Intervention Referral to Treatment (SBIRT), in the primary care setting has faced several challeng...
Detailed Description
Study Objectives: 1. Enhance the Screening Brief Intervention Referral to Treatment (SBIRT) with a digital tool that aims to save physicians time and improve patient adherence to treatment goals, thr...
Eligibility Criteria
Inclusion
- Participants will be included if they:
- Do not answer "Never'' for TASP1 Q2 or Q3, Q4 \& Q5.
- Age 21 or older.
- Able to read and speak English.
- Able to provide written informed consent.
- Have access to a personal data enabled Mobile device for messaging.
Exclusion
- Participants will be excluded if they meet one or more of the following criteria:
- Answer " "Never" for TAPS1 Q2 or Q3, Q4 \& Q5
- Currently in Substance abuse treatment.
- Have had previous substance use disorder (SUD) diagnosis less than a year ago.
- Were in a psychiatric hospital, or attempted suicide in the last 6 months.
- Have any other medical or psychiatric condition that the PIs determine would compromise safe study participation (e.g., terminal medical condition, recent myocardial infarction).
- Are pregnant.
- In the clinic for urgent conditions.
Key Trial Info
Start Date :
September 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04401215
Start Date
September 23 2019
End Date
February 28 2020
Last Update
June 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHAS Valley Clinic
Spokane Valley, Washington, United States, 99216